世界の肺炎市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pneumonia Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4671 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、肺炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン、酸素療法）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺炎の市場動向 ・企業の競争状況、市場シェア ・肺炎の種類別市場規模（治療薬、ワクチン、酸素療法） ・肺炎の用途別市場規模（病院、外来手術センター、その他） ・肺炎の北米市場規模2016-2027（アメリカ、カナダ） ・肺炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・肺炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、GlaxoSmithKline(GSK)、Merck、Novartis、Sanofi、Eli Lilly） ・結論

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.

Market Analysis and Insights: Global Pneumonia Market
The global Pneumonia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pneumonia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pneumonia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pneumonia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pneumonia market.

Global Pneumonia Scope and Market Size
Pneumonia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Vaccines
Oxygen Therapy

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Vaccines
1.2.4 Oxygen Therapy
1.3 Market by Application
1.3.1 Global Pneumonia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pneumonia Market Perspective (2016-2027)
2.2 Pneumonia Growth Trends by Regions
2.2.1 Pneumonia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pneumonia Historic Market Share by Regions (2016-2021)
2.2.3 Pneumonia Forecasted Market Size by Regions (2022-2027)
2.3 Pneumonia Industry Dynamic
2.3.1 Pneumonia Market Trends
2.3.2 Pneumonia Market Drivers
2.3.3 Pneumonia Market Challenges
2.3.4 Pneumonia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Players by Revenue
3.1.1 Global Top Pneumonia Players by Revenue (2016-2021)
3.1.2 Global Pneumonia Revenue Market Share by Players (2016-2021)
3.2 Global Pneumonia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pneumonia Revenue
3.4 Global Pneumonia Market Concentration Ratio
3.4.1 Global Pneumonia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Revenue in 2020
3.5 Pneumonia Key Players Head office and Area Served
3.6 Key Players Pneumonia Product Solution and Service
3.7 Date of Enter into Pneumonia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pneumonia Breakdown Data by Type
4.1 Global Pneumonia Historic Market Size by Type (2016-2021)
4.2 Global Pneumonia Forecasted Market Size by Type (2022-2027)

5 Pneumonia Breakdown Data by Application
5.1 Global Pneumonia Historic Market Size by Application (2016-2021)
5.2 Global Pneumonia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pneumonia Market Size (2016-2027)
6.2 North America Pneumonia Market Size by Type
6.2.1 North America Pneumonia Market Size by Type (2016-2021)
6.2.2 North America Pneumonia Market Size by Type (2022-2027)
6.2.3 North America Pneumonia Market Size by Type (2016-2027)
6.3 North America Pneumonia Market Size by Application
6.3.1 North America Pneumonia Market Size by Application (2016-2021)
6.3.2 North America Pneumonia Market Size by Application (2022-2027)
6.3.3 North America Pneumonia Market Size by Application (2016-2027)
6.4 North America Pneumonia Market Size by Country
6.4.1 North America Pneumonia Market Size by Country (2016-2021)
6.4.2 North America Pneumonia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pneumonia Market Size (2016-2027)
7.2 Europe Pneumonia Market Size by Type
7.2.1 Europe Pneumonia Market Size by Type (2016-2021)
7.2.2 Europe Pneumonia Market Size by Type (2022-2027)
7.2.3 Europe Pneumonia Market Size by Type (2016-2027)
7.3 Europe Pneumonia Market Size by Application
7.3.1 Europe Pneumonia Market Size by Application (2016-2021)
7.3.2 Europe Pneumonia Market Size by Application (2022-2027)
7.3.3 Europe Pneumonia Market Size by Application (2016-2027)
7.4 Europe Pneumonia Market Size by Country
7.4.1 Europe Pneumonia Market Size by Country (2016-2021)
7.4.2 Europe Pneumonia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Market Size (2016-2027)
8.2 Asia-Pacific Pneumonia Market Size by Type
8.2.1 Asia-Pacific Pneumonia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pneumonia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pneumonia Market Size by Type (2016-2027)
8.3 Asia-Pacific Pneumonia Market Size by Application
8.3.1 Asia-Pacific Pneumonia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pneumonia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pneumonia Market Size by Application (2016-2027)
8.4 Asia-Pacific Pneumonia Market Size by Region
8.4.1 Asia-Pacific Pneumonia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pneumonia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pneumonia Market Size (2016-2027)
9.2 Latin America Pneumonia Market Size by Type
9.2.1 Latin America Pneumonia Market Size by Type (2016-2021)
9.2.2 Latin America Pneumonia Market Size by Type (2022-2027)
9.2.3 Latin America Pneumonia Market Size by Type (2016-2027)
9.3 Latin America Pneumonia Market Size by Application
9.3.1 Latin America Pneumonia Market Size by Application (2016-2021)
9.3.2 Latin America Pneumonia Market Size by Application (2022-2027)
9.3.3 Latin America Pneumonia Market Size by Application (2016-2027)
9.4 Latin America Pneumonia Market Size by Country
9.4.1 Latin America Pneumonia Market Size by Country (2016-2021)
9.4.2 Latin America Pneumonia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Market Size (2016-2027)
10.2 Middle East & Africa Pneumonia Market Size by Type
10.2.1 Middle East & Africa Pneumonia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pneumonia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pneumonia Market Size by Type (2016-2027)
10.3 Middle East & Africa Pneumonia Market Size by Application
10.3.1 Middle East & Africa Pneumonia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pneumonia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pneumonia Market Size by Application (2016-2027)
10.4 Middle East & Africa Pneumonia Market Size by Country
10.4.1 Middle East & Africa Pneumonia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pneumonia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pneumonia Introduction
11.1.4 Pfizer Revenue in Pneumonia Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Details
11.2.2 GlaxoSmithKline(GSK) Business Overview
11.2.3 GlaxoSmithKline(GSK) Pneumonia Introduction
11.2.4 GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2016-2021)
11.2.5 GlaxoSmithKline(GSK) Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Pneumonia Introduction
11.3.4 Merck Revenue in Pneumonia Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Pneumonia Introduction
11.4.4 Novartis Revenue in Pneumonia Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Pneumonia Introduction
11.5.4 Sanofi Revenue in Pneumonia Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Pneumonia Introduction
11.6.4 Eli Lilly Revenue in Pneumonia Business (2016-2021)
11.6.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pneumonia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccines
Table 4. Key Players of Oxygen Therapy
Table 5. Global Pneumonia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pneumonia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pneumonia Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pneumonia Market Share by Regions (2016-2021)
Table 9. Global Pneumonia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pneumonia Market Share by Regions (2022-2027)
Table 11. Pneumonia Market Trends
Table 12. Pneumonia Market Drivers
Table 13. Pneumonia Market Challenges
Table 14. Pneumonia Market Restraints
Table 15. Global Pneumonia Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pneumonia Market Share by Players (2016-2021)
Table 17. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia as of 2020)
Table 18. Ranking of Global Top Pneumonia Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pneumonia Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pneumonia Product Solution and Service
Table 22. Date of Enter into Pneumonia Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pneumonia Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pneumonia Revenue Market Share by Type (2016-2021)
Table 26. Global Pneumonia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pneumonia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pneumonia Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pneumonia Revenue Market Share by Application (2016-2021)
Table 30. Global Pneumonia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pneumonia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pneumonia Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pneumonia Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pneumonia Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pneumonia Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pneumonia Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pneumonia Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pneumonia Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pneumonia Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pneumonia Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pneumonia Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pneumonia Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pneumonia Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pneumonia Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pneumonia Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pneumonia Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pneumonia Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pneumonia Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pneumonia Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pneumonia Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pneumonia Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pneumonia Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pneumonia Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pneumonia Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pneumonia Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pneumonia Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pneumonia Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pneumonia Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pneumonia Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pneumonia Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pneumonia Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Pneumonia Product
Table 65. Pfizer Revenue in Pneumonia Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. GlaxoSmithKline(GSK) Company Details
Table 68. GlaxoSmithKline(GSK) Business Overview
Table 69. GlaxoSmithKline(GSK) Pneumonia Product
Table 70. GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline(GSK) Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Pneumonia Product
Table 75. Merck Revenue in Pneumonia Business (2016-2021) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Pneumonia Product
Table 80. Novartis Revenue in Pneumonia Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Pneumonia Product
Table 85. Sanofi Revenue in Pneumonia Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Pneumonia Product
Table 90. Eli Lilly Revenue in Pneumonia Business (2016-2021) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Vaccines Features
Figure 4. Oxygen Therapy Features
Figure 5. Global Pneumonia Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Pneumonia Report Years Considered
Figure 10. Global Pneumonia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pneumonia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pneumonia Market Share by Regions: 2020 VS 2027
Figure 13. Global Pneumonia Market Share by Regions (2022-2027)
Figure 14. Global Pneumonia Market Share by Players in 2020
Figure 15. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pneumonia Revenue in 2020
Figure 17. Global Pneumonia Revenue Market Share by Type (2016-2021)
Figure 18. Global Pneumonia Revenue Market Share by Type (2022-2027)
Figure 19. North America Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pneumonia Market Share by Type (2016-2027)
Figure 21. North America Pneumonia Market Share by Application (2016-2027)
Figure 22. North America Pneumonia Market Share by Country (2016-2027)
Figure 23. United States Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pneumonia Market Share by Type (2016-2027)
Figure 27. Europe Pneumonia Market Share by Application (2016-2027)
Figure 28. Europe Pneumonia Market Share by Country (2016-2027)
Figure 29. Germany Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pneumonia Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pneumonia Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pneumonia Market Share by Region (2016-2027)
Figure 39. China Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pneumonia Market Share by Type (2016-2027)
Figure 47. Latin America Pneumonia Market Share by Application (2016-2027)
Figure 48. Latin America Pneumonia Market Share by Country (2016-2027)
Figure 49. Mexico Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pneumonia Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pneumonia Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pneumonia Market Share by Country (2016-2027)
Figure 55. Turkey Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pneumonia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Pneumonia Business (2016-2021)
Figure 59. GlaxoSmithKline(GSK) Revenue Growth Rate in Pneumonia Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Pneumonia Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Pneumonia Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Pneumonia Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Pneumonia Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---